Shenzhen Lifotronic Technology Past Earnings Performance
Past criteria checks 4/6
Shenzhen Lifotronic Technology has been growing earnings at an average annual rate of 26.7%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 22.2% per year. Shenzhen Lifotronic Technology's return on equity is 19.5%, and it has net margins of 31.9%.
Key information
26.7%
Earnings growth rate
25.6%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 22.2% |
| Return on equity | 19.5% |
| Net Margin | 31.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?
Oct 24
Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump
Oct 02Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital
Aug 16Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?
Jul 25Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E
May 24Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger
Apr 17Revenue & Expenses Breakdown
How Shenzhen Lifotronic Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,193 | 381 | 239 | 183 |
| 30 Jun 24 | 1,177 | 366 | 256 | 171 |
| 31 Mar 24 | 1,174 | 348 | 266 | 174 |
| 31 Dec 23 | 1,146 | 329 | 260 | 170 |
| 30 Sep 23 | 1,119 | 303 | 263 | 170 |
| 30 Jun 23 | 1,095 | 286 | 240 | 176 |
| 31 Mar 23 | 1,051 | 272 | 217 | 171 |
| 31 Dec 22 | 983 | 251 | 196 | 171 |
| 30 Sep 22 | 907 | 221 | 179 | 177 |
| 30 Jun 22 | 869 | 207 | 171 | 177 |
| 31 Mar 22 | 824 | 203 | 158 | 162 |
| 31 Dec 21 | 778 | 190 | 157 | 156 |
| 30 Sep 21 | 705 | 173 | 147 | 148 |
| 30 Jun 21 | 651 | 157 | 138 | 132 |
| 31 Mar 21 | 596 | 160 | 123 | 112 |
| 31 Dec 20 | 554 | 144 | 116 | 103 |
| 30 Sep 20 | 516 | 127 | 118 | 97 |
| 30 Jun 20 | 477 | 119 | 111 | 88 |
| 31 Mar 20 | 450 | 111 | 106 | 81 |
| 31 Dec 19 | 423 | 101 | 99 | 78 |
| 30 Sep 19 | 400 | 102 | 103 | 70 |
| 31 Dec 18 | 323 | 81 | 83 | 67 |
| 31 Dec 17 | 251 | 56 | 66 | 50 |
| 31 Dec 16 | 175 | 10 | 75 | 39 |
Quality Earnings: 688389 has high quality earnings.
Growing Profit Margin: 688389's current net profit margins (31.9%) are higher than last year (27.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688389's earnings have grown significantly by 26.7% per year over the past 5 years.
Accelerating Growth: 688389's earnings growth over the past year (25.6%) is below its 5-year average (26.7% per year).
Earnings vs Industry: 688389 earnings growth over the past year (25.6%) exceeded the Medical Equipment industry -8.8%.
Return on Equity
High ROE: 688389's Return on Equity (19.5%) is considered low.